An audit on the monitoring of mood stabilisers

Cookson J. Lithium: balancing risk and benefits. Br J Psychiatry 1997;178:120-4

Tondo L, Baldessarini RJ, Floris G. Long term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorder. Br J Psychiatry 2001;178(Suppl 41):184-90

Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex sodium vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271(12):918-24

Freeman TW, Clothier JL, Pazzaglia P, Lessem MD, Swann AC. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiatry 1992;149(1):108-11. Available from: https://doi.org/10.1176/ajp.149.1.108

Janicak PG. The relevance of clinical pharmacokinetics and therapeutic drug monitoring: anticonvulsant mood stabilisers and anti-psychotic. J Clin Psychiatry 1993;54 Suppl:35-41

National Institute for Clinical Excellence. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. National Clinical Practical Guideline Number 38. NICE 2006

Goodwin GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003:17(2);149-79. Available from: https://doi.org/10.1177/0269881103017002003

Bipolar disorder. IN Taylor D, Parton C, Kerwin R, Eds. The Maudsley 2005-2006 Prescribing Guidelines. 8th Ed. London: Informa Healthcare; 2005:pp107-34